Soleno Therapeutics, Inc. (SLNO)
39.49
+2.50
(+6.76%)
USD |
NASDAQ |
Apr 02, 16:00
39.99
+0.50
(+1.27%)
Pre-Market: 20:00
Soleno Therapeutics EPS Diluted (Quarterly) : 0.7904 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| Integer Holdings Corp. | 1.383 |
| Boston Scientific Corp. | 0.4493 |
| Molina Healthcare, Inc. | -3.137 |
| MannKind Corp. | -0.0519 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 42.94M |
| Revenue (Quarterly) | 91.73M |
| Total Expenses (Quarterly) | 48.79M |
| Enterprise Value | 1.786B |
| Gross Profit Margin (Quarterly) | 99.06% |
| Profit Margin (Quarterly) | 46.81% |
| Earnings Yield | 0.56% |
| Operating Earnings Yield | 0.74% |
| Normalized Earnings Yield | 0.7645 |